当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析

方盛制药

(603998)

  

流通市值:53.52亿  总市值:53.52亿
流通股本:4.39亿   总股本:4.39亿

方盛制药(603998)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.66亿元,每股收益0.39元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益171474.69万元,未分配利润89248.73万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产305654.32万元,负债134179.63万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入834,248,975.63418,083,503.371,777,494,393.871,347,963,171.04
营业总成本683,068,914.91340,146,773.391,531,784,897.551,150,514,693.55
其他经营收益
营业利润187,112,626.8499,305,191.5285,344,284.91249,015,829.13
利润总额186,493,310.7199,168,320.14285,987,541.69249,980,029.93
净利润166,494,080.2288,724,501.72249,848,866.44227,396,741.19
每股收益
其他综合收益----
综合收益总额166,494,080.2288,724,501.72249,848,866.44227,396,741.19
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计940,136,070.641,007,066,535.21,137,539,132.241,044,743,627.41
非流动资产:
非流动资产合计2,116,407,088.062,142,934,073.892,129,034,332.352,241,421,440.8
资产总计3,056,543,158.73,150,000,609.093,266,573,464.593,286,165,068.21
流动负债:
流动负债合计1,167,605,565.81,214,371,255.411,298,529,448.161,394,894,580.9
非流动负债:
非流动负债合计174,190,717.88176,143,794.69233,175,717.78179,903,075.33
负债合计1,341,796,283.681,390,515,050.11,531,705,165.941,574,797,656.23
所有者权益(或股东权益):
归属于母公司股东权益合计1,638,839,547.981,666,208,152.731,622,965,416.791,595,047,837.87
股东权益合计1,714,746,875.021,759,485,558.991,734,868,298.651,711,367,411.99
负债和股东权益合计3,056,543,158.73,150,000,609.093,266,573,464.593,286,165,068.21
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计837,217,170.97394,398,253.081,822,980,615.311,355,541,917.05
经营活动现金流出小计707,728,803.3372,472,153.731,628,033,176.751,238,554,589.24
经营活动产生的现金流量净额129,488,367.6721,926,099.35194,947,438.56116,987,327.81
投资活动产生的现金流量:
投资活动现金流入小计320,696,460.3379,147,130.64213,501,716.3113,435,934.31
投资活动现金流出小计307,298,903.2877,932,275.96172,458,127.7151,157,951.56
投资活动产生的现金流量净额13,397,557.051,214,854.6841,043,588.6-37,722,017.25
筹资活动产生的现金流量:
筹资活动现金流入小计334,025,000157,325,000910,594,583.33622,164,583.33
筹资活动现金流出小计658,260,770.36303,674,023.621,032,594,628.44704,629,449.08
筹资活动产生的现金流量净额-324,235,770.36-146,349,023.62-122,000,045.11-82,464,865.75
汇率变动对现金及现金等价物的影响-0.19-0.060.670.87
现金及现金等价物净增加额-181,349,845.83-123,208,069.65113,990,982.72-3,199,554.32
期末现金及现金等价物余额114,672,186.92172,813,963.89296,022,032.75178,831,495.71
补充资料:
现金及现金等价物的净增加额-181,349,845.83-113,990,982.72-
最新报告期:2025-09-03
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华源证券刘闯0.780.901.042025-09-03
华泰证券代雯,唐庆雷,张云逸0.700.831.002025-08-30
开源证券余汝意,巢舒然0.700.861.042025-08-29
TOP↑